COVID-19 Cases Rise: Should you be worried and take immediate precautions? Here's complete list of affected states, other details
COVID-19 cases are increasing in the United States, with the Centers for Disease Control and Prevention (CDC) reporting growing or likely growing case numbers in at least 26 states and Washington, D.C. The spike coincides with new variants and shifting guidance on vaccination.CDC data shows that COVID-19 cases are either increasing or likely increasing in most regions. The states currently reporting growing cases include:
Arkansas
Hawaii
Illinois
Iowa
Kentucky
North Carolina
Ohio
Pennsylvania
Texas
Virginia In addition, the following locations are seeing a likely increase: Alaska
California
Delaware
District of Columbia
Georgia
Indiana
Maine
Maryland
Massachusetts
Michigan
Mississippi
New Jersey
New York
Oklahoma
South Carolina
Tennessee
Wisconsin
According to CDC tracking, COVID-related emergency room visits for children under the age of 5 are at their highest since March. This group remains among the most vulnerable, as they cannot yet receive their own vaccine doses.
Also Read: World's Best International Airports: Who tops the list and why? Here's Top 10 list, rankings, Travel + Leisure 2025 survey criteria and points
Dr. Jon LaPook, chief medical correspondent for CBS News, said the rise is part of an annual pattern now observed since the pandemic began. He confirmed there are winter and summer spikes. He added that although the overall number of hospitalizations and deaths is decreasing each year, COVID-19 still poses risks to certain groups. These include children under 4, older adults, and immunocompromised individuals.The recent increase in cases has been linked to new variants named Nimbus and Stratus. Dr. LaPook stated that these are not more dangerous than earlier variants. Symptoms continue to include cough, sore throat, fever, and fatigue.Earlier variants like NB.1.8.1 also showed no increase in disease severity. The new seasonal vaccines are designed to protect against current circulating strains, including Nimbus and Stratus.
Also Read: Don't Tap the Glass Release: Tyler, The Creator's Album takes social media by storm, sparks meme fest. Here's complete track list, run time, reactions
The CDC and other health organizations have differing guidance on vaccines. The CDC encourages shared clinical decision-making, especially for healthy children. Most adults are recommended to receive the 2024–2025 COVID-19 vaccine, particularly if they: Are 65 years or older
Are at high risk for severe COVID-19
Have never received a vaccine Some organizations, like the American College of Obstetricians and Gynecologists, continue to recommend vaccination during pregnancy. This helps transfer antibodies from the mother to the baby before the infant becomes eligible for their own shots.Health and Human Services Secretary Robert F. Kennedy Jr. noted that vaccine decisions should be made in consultation with medical professionals.
Are the new COVID-19 variants Nimbus and Stratus more severe than previous ones?
No. Experts say symptoms are similar to earlier variants. They include cough, sore throat, fever, and fatigue. Hospitalization rates have not shown an increase.
Should everyone get the 2024–2025 COVID-19 vaccine?
The CDC advises most adults to get it, especially older adults or those at risk. Others should discuss it with their healthcare provider.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
an hour ago
- Indian Express
Why minimum standards for handling diagnostic samples are important
The Union Ministry of Health and Family Welfare (MoHFW) last week assured the Delhi High Court that it will soon notify minimum clinical standards for collection, handling, and transport of diagnostic samples. The MoHFW said that subject experts held 'detailed internal deliberations for formulating minimum standards' following which the draft minimum standards were finalised. The policy is currently being vetted by the legislative department of the Ministry of Law & Justice, the MoHFW told the court. Existing Indian Council of Medical Research (ICMR) guidelines on collection and handling of clinical samples are rudimentary and piecemeal. For instance, the Pune-based ICMR-National Institute of Virology (NIV) has specific 'Guidelines for collection, packaging and transport of specimens for testing for high risk viral pathogens', which include guidelines for handling samples containing Covid-19 virus. These guidelines, however, are not comprehensive: they only relate to handling of specific 'high risk' viruses. These are also not uniformly enforced owing to gaps in the law governing labs and sample collection centres, as well as its enforcement. Medical professionals have long been calling for reform; the MoHFW's soon-to-be-notified policy seeks to answer this call. Beyond lack of comprehensive clinical guidelines, experts have pointed to a couple of significant loopholes vis-à-vis the medical testing ecosystem. 🔴 First is the continued existence of standalone collection centres. In 2018, the Centre had notified that sample collection centres should be part of the main laboratories, and that the parent laboratories should be held accountable for their compliance of norms. But in the absence of clear-cut standards, standalone collection centres continue to be registered in various states, posing a fundamental problem when it comes to ensuring compliance with clinical standards. In November 2020, the National Accreditation Board for Testing and Calibration Laboratories (NABL) had flagged that 'there are mismatches in the declaration (of samples) made by (accredited) lab to NABL and the actual collection centres/facilities/sources of collection which are available on their websites or other documents'. At the time, it advised labs to declare all sample collection centres within 30 days, and cautioned that 'any sample collection not under the responsibility of the lab and not covered under its (quality) management system is non-compliant with the accreditation norms and liable to action by NABL.' The MoHFW's new policy will likely address this issue. 🔴 Experts have also called for revisiting current laws guiding 'who' can collect samples and issue reports. In 2019, pathologist Dr Rohit Jain moved the Delhi High Court, challenging the Clinical Establishments (Central Government) Amendment Rules 2018, specifically on minimum requirements for signatory authorities in diagnostic laboratories. He sought implementation of a 2017 order of the Supreme Court, which said that a lab report should be counter-signed only by a registered medical practitioner with a post graduate qualification in pathology. At the time, he also sought guidelines on minimum standards for medical diagnostic labs with regard to sample collection centres, sample transport, electronic signatures on pathological reports by authorised signatories, number of pathology labs a pathologist can visit in a day and on daily internal quality control. But the Centre's Clinical Establishment (Central Government) Amendment Rules 2020 did not address the issue, allowing 'unqualified and unregistered non-medical persons viz MSc/PhD were authorised to issue pathology reports without the signature/counter signature of a pathologist,' according to Jain. Jain challenged these amended rules, and in August 2021, also moved court highlighting an RT-PCR testing 'scam' during the Kumbh Mela in Haridwar that year where one lakh fake tests were reportedly conducted on devotees by unqualified intermediaries. 'The accused diagnostic labs in Delhi and Haryana were able to collect samples and conduct a huge number of tests where they have no sample collection centres at Uttarakhand. It is clear that a scam of such enormity has only been possible because of the lack of essential minimum standards on the issue of sample collection/sample collection centres and sample transport policy,' Jain had argued in his submission. In 2023, the Delhi High Court directed the Centre to consider Jain's plea as a representation and decide a solution in three months. In May 2023, the government held a meeting under the chairmanship of the Additional Director-General of Health Services, New Delhi, where Jain too was invited to make his representation. After the meeting, the government decided to constitute four sub-committees of experts — pathology, biochemistry, hematology and microbiology — to define standards of procedure (SOPs) for sample collection, collection centres and sample transport policy. When these guidelines were not notified even a year later, Jain in May 2024 moved the Delhi High Court again, accusing the government of wilful disobedience of the court's order. It is in this matter that the MoHFW has now assured the court that a policy will be notified at the earliest. Taking the ministry's submission on record, the court instructed that the standards be notified expeditiously, with a direction that the process 'may be accomplished within the next three months'.
Time of India
2 hours ago
- Time of India
West Nile virus cases surge in the US: How to spot the first symptoms of the infection before it gets serious
It starts like a summer itch. You swat away a mosquito, maybe curse the humidity, then carry on. But what if that bite is more than a nuisance? What if it's carrying something far more dangerous? As temperatures climb and mosquito season hits full swing, West Nile virus (WNV) is making headlines again. Across several US states, public health officials are reporting a spike in confirmed West Nile infections, and the numbers are creeping up faster than usual this year. The Centers for Disease Control and Prevention (CDC) first confirmed a case of West Nile virus in June, involving a patient from Southern Illinois who was hospitalized with serious complications. A second case was reported in Lake County on July 16, where a resident in their 70s fell ill earlier in the month, marking another confirmed infection during this year's mosquito season. So, what's going on? And more importantly how can you tell the difference between a bug bite and something more dangerous? West Nile virus is a mosquito-borne illness that spreads when an infected mosquito bites you. Birds are the virus's preferred host, but mosquitos are the ones doing all the dirty work—biting infected birds and then passing the virus to humans. Most cases happen during the warmest months, especially July through September. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 20 Pieces of Clothing you Can be Too Old for Learn More Undo And while the majority of people infected with the virus don't show any symptoms at all, a small percentage get very sick and some of those cases can turn fatal. First symptoms of West Nile virus Here's where things get tricky. About 8 out of 10 people infected with WNV never feel a thing. But the remaining 20%? They're hit with something called West Nile fever—and it's not pretty. The first signs usually show up 2 to 14 days after a mosquito bite, and can include: Fever (mild to high) Headache Fatigue or feeling 'off' Body aches and joint pain Skin rash (sometimes) Swollen lymph nodes Eye pain or light sensitivity Sounds like the flu, right? Or COVID. Or just a really bad Monday. That's what makes early detection so tricky, it hides in plain sight. If you're otherwise healthy, you'll likely recover on your own in about a week or two. But here's the kicker: in rare cases, the virus can invade your nervous system. That's where things get serious. Neuroinvasive West Nile: When it becomes dangerous In less than 1% of cases, WNV can lead to something called neuroinvasive disease—meaning the virus makes its way into your brain or spinal cord. This can cause: Encephalitis (inflammation of the brain) Meningitis (inflammation of the membranes around your brain and spinal cord) Acute flaccid paralysis (a sudden, polio-like paralysis) The symptoms of severe WNV infection include: High fever Severe headache Neck stiffness Disorientation or confusion Tremors or seizures Muscle weakness Coma If you or someone you know starts showing these signs after mosquito exposure, go to a hospital immediately. Time matters. Who's most at risk? Anyone can get West Nile, but adults over 60, people with weakened immune systems, and those with chronic conditions (like diabetes or kidney disease) are at higher risk for severe symptoms. But don't let your age fool you. There have been fatal cases in young, otherwise healthy people too—so no one gets a free pass. How to protect yourself this mosquito season Okay, now that we've scared you just enough to take this seriously, here's the good news: prevention works. Simple steps make a big difference: Wear insect repellent with DEET, picaridin, or oil of lemon eucalyptus Cover up with long sleeves and pants when outdoors, especially at dawn and dusk Dump standing water in birdbaths, plant trays, buckets—mosquitoes love it Fix screens on windows and doors to keep the buzzers out Stay in air-conditioned spaces when possible And no, citronella candles don't count as mosquito armor. So the next time you brush off a mosquito bite, pay attention to your body in the days that follow. A mild headache might just be stress… or it could be your early warning sign. West Nile virus FAQs What are the first signs of West Nile Virus in humans? The most common early symptoms include fever, headache, body aches, fatigue, and sometimes a rash. These can appear 2 to 14 days after a mosquito bite. Many people confuse them with the flu or just feeling run-down. How do you catch West Nile Virus? You get infected through the bite of a mosquito that has fed on an infected bird. It's not contagious between people, and you can't get it through touching or casual contact. Can West Nile Virus be cured? There is no specific cure or antiviral treatment for West Nile Virus. Most people recover on their own, but severe cases may require hospitalization for supportive care like IV fluids and pain management. Who is most at risk for serious complications? People over age 60, and those with weakened immune systems, cancer, diabetes, or kidney disease, are more likely to develop serious forms like meningitis or encephalitis. Is there a vaccine for West Nile Virus? As of now, no vaccine is available for humans—though one exists for horses. Prevention relies on mosquito control and personal protection, like using repellent and avoiding peak mosquito hours.
Time of India
4 hours ago
- Time of India
2,426 cr Covid fight bill hit state economy hard: Report
1 2 3 Visakhapatnam: The Covid-19 pandemic not only triggered a public health emergency but also imposed significant financial pressure on the Andhra Pradesh exchequer. Between 2019–20 and 2022–23, the state incurred an expenditure of 4,606 crore on various Covid-19 prevention and management measures, according to the CAG report. Andhra Pradesh was among the hardest-hit states, recording over 23 lakh cases—ranking fifth in the country in terms of case load. In response to the emerging crisis, the state ramped up healthcare infrastructure beginning February 2020. Key initiatives included setting up diagnostic labs, expanding testing capacity, procuring medicines and vaccines, strengthening oxygen supply networks, and mobilizing critical medical resources. Although public health is a state responsibility, the Union Ministry of Health and Family Welfare provided both technical and financial aid to assist states in managing the pandemic. The Centre introduced the Emergency Covid Response Package (ECRP) to curb transmission and mitigate impact. Under ECRP-I, funds released to Andhra Pradesh in FY 2020–21 were fully borne by the Centre. In 2021–22, the funding was shared between Centre and state in a 60:40 ratio. According to the CAG report, during the four-year period, Andhra Pradesh received a total allocation of 4,961.36 crore (both Central and state share) and spent 4,606 crore. Of this, the state govt on its part spent 2,426.47 crore. GoI's share amounted to 1,876.44 crore, of which 1,612.45 crore was utilised. From the state disaster response fund, 140.95 crore was used out of the allocated 187.87 crore. Meanwhile, 426.13 crore was spent from the district mineral fund, against an allocation of 534.41 crore. At the onset of the pandemic in Feb 2020, Andhra Pradesh had no Covid-19 testing infrastructure. The state responded swiftly by establishing 135 testing laboratories. Until these labs became operational, test samples had to be sent to other states for processing. During the second wave, the state expanded the number of Covid-19 treatment hospitals from 260 in the first wave to over 640. It also ramped up human resources, recruiting 17,300 doctors and support staff during the first wave, and an additional 18,000 medical personnel during the second wave. Notably, Andhra Pradesh became one of the few states in India to achieve 100% double-dose vaccination coverage among eligible population groups. In a major welfare initiative, Andhra Pradesh became the first state in the country to include Covid-19 treatment under its flagship Arogyasri health scheme (now renamed as NTR Vaidya Seva). This decision enabled over 1 lakh patients to receive free inpatient treatment at private hospitals across the state.
